| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1100-1108, Copyright © 1994 by Endocrine Society
ARTICLES |
J Herrington and B Hille
Department of Physiology and Biophysics, University of Washington, Seattle 98195.
The actions of GH-releasing hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys- NH2 or GHRP-6) on single rat somatotropes were studied using whole cell patch clamp electrophysiology and indo-1 Ca2+ photometry. GHRP-6 elevated intracellular free Ca2+ ([Ca2+]i) in two phases: a rapid transient phase, followed by a persistent phase. Based on its insensitivity to treatments that block Ca2+ entry [removal of external Ca2+, addition of the dihydropyridine Ca2+ channel blocker nitrendipine (1 microM), and the hyperpolarizing action of zero external Na+ or 100 nM somatostatin], the transient elevation is the result of release of Ca2+ from intracellular stores. The half-maximal concentration for the peak [Ca2+]i rise during Ca2+ release was 49 nM GHRP-6. Prior treatment of cells with caffeine (10 mM) or ryanodine (50 microM) abolished or partially occluded GHRP-6-induced Ca2+ release. Simultaneous measurement of [Ca2+]i and membrane current or potential revealed that the transient release of Ca2+ by GHRP-6 activates a voltage-independent Ca(2+)-activated K+ conductance, which transiently hyperpolarizes the somatotrope. The GHRP-6-induced persistent [Ca2+]i elevation is abolished by removal of external Ca2+ or external Na+ or the addition of 1 microM nitrendipine or 100 nM somatostatin, consistent with Ca2+ entry through voltage-dependent Ca2+ channels. In nondialyzed cells (perforated patch recording), we have identified a long-lasting GHRP-6- induced depolarization which may be responsible for the persistent [Ca2+]i elevation.
This article has been cited by other articles:
![]() |
K. Dezaki, M. Kakei, and T. Yada Ghrelin Uses G{alpha}i2 and Activates Voltage-Dependent K+ Channels to Attenuate Glucose-Induced Ca2+ Signaling and Insulin Release in Islet {beta}-Cells: Novel Signal Transduction of Ghrelin Diabetes, September 1, 2007; 56(9): 2319 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Malagon, R. M. Luque, E. Ruiz-Guerrero, F. Rodriguez-Pacheco, S. Garcia-Navarro, F. F. Casanueva, F. Gracia-Navarro, and J. P. Castano Intracellular Signaling Mechanisms Mediating Ghrelin-Stimulated Growth Hormone Release in Somatotropes Endocrinology, December 1, 2003; 144(12): 5372 - 5380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. H. Wong, J. D. Johnson, W. K. Yunker, and J. P. Chang Caffeine stores and dopamine differentially require Ca2+ channels in goldfish somatotropes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R494 - R503. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Weekers, E. Van Herck, J. Isgaard, and G. Van den Berghe Pretreatment with Growth Hormone-Releasing Peptide-2 Directly Protects against the Diastolic Dysfunction of Myocardial Stunning in an Isolated, Blood-Perfused Rabbit Heart Model Endocrinology, November 1, 2000; 141(11): 3993 - 3999. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. El Meskini, R. E. Mains, and B. A. Eipper Cell Type-Specific Metabolism of Peptidylglycine {alpha}-Amidating Monooxygenase in Anterior Pituitary Endocrinology, August 1, 2000; 141(8): 3020 - 3034. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Negishi, C. L. Chik, and A. K. Ho Ceramide Enhances Growth Hormone (GH)-Releasing Hormone-Stimulated Cyclic Adenosine 3',5'-Monophosphate Accumulation but Inhibits GH Release in Rat Anterior Pituitary Cells Endocrinology, December 1, 1999; 140(12): 5691 - 5697. [Abstract] [Full Text] |
||||
![]() |
N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis Tripartite Neuroendocrine Activation of the Human Growth Hormone (GH) Axis in Women by Continuous 24-Hour GH-Releasing Peptide Infusion: Pulsatile, Entropic, and Nyctohemeral Mechanisms J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2140 - 2150. [Abstract] [Full Text] |
||||
![]() |
J. L. Ramírez, J. P. Castaño, R. Torronteras, A. J. Martínez-Fuentes, L. S. Frawley, S. García-Navarro, and F. Gracia-Navarro Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations Endocrinology, April 1, 1999; 140(4): 1752 - 1759. [Abstract] [Full Text] |
||||
![]() |
M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320. [Abstract] [Full Text] |
||||
![]() |
S. Nielsen, S. Mellemkjær, L. M. Rasmussen, T. Ledet, J. Astrup, J. Weeke, and J. O. L. Jørgensen Gene Transcription of Receptors for Growth Hormone-Releasing Peptide and Somatostatin in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2997 - 3000. [Abstract] [Full Text] |
||||
![]() |
J. Billiard, D.-S. Koh, D. F. Babcock, and B. Hille Protein kinase C as a signal for exocytosis PNAS, October 28, 1997; 94(22): 12192 - 12197. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett Peptidomimetic Regulation of Growth Hormone Secretion Endocr. Rev., October 1, 1997; 18(5): 621 - 645. [Abstract] [Full Text] |
||||
![]() |
S. Sundaresan, J. Weiss, A. C. Bauer-Dantoin, and J. L. Jameson Expression of Ryanodine Receptors in the Pituitary Gland: Evidence for a Role in Gonadotropin-Releasing Hormone Signaling Endocrinology, May 1, 1997; 138(5): 2056 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Andric, T. S. Kostic, M. Tomic', T.-a. Koshimizu, and S. S. Stojilkovic Dependence of Soluble Guanylyl Cyclase Activity on Calcium Signaling in Pituitary Cells J. Biol. Chem., January 5, 2001; 276(1): 844 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Johnson, C. Klausen, H. R. Habibi, and J. P. Chang Function-specific calcium stores selectively regulate growth hormone secretion, storage, and mRNA level Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E810 - E819. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |